MedPath

A clinical trial to study the effect of Ayurveda in patients with duchenne muscular dystrophy

Phase 3
Conditions
Health Condition 1: G710- Muscular dystrophy
Registration Number
CTRI/2022/04/042342
Lead Sponsor
Dr Rashmi R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Genetically confirmed ambulant patients of Duchenne Muscular Dystrophy (DMD) with elevated serum creatinine kinase

Clinical signs consistent with DMD like progressive loss of function

delayed walking

frequent falls

di?culty with running and climbing stairs

positive Gower sign and calf pseudohypertrophy

Exclusion Criteria

Non-ambulant patients with advanced symptoms of cardiomyopathy and respiratory complications

Other muscular dystrophies and myopathies like becker muscular dystrophy, congenital muscular dystrophies - myelopathies, congenital myopathies and metabolic muscle diseases

Evidence of any malignancy

With contraindications for TMS like major head injury, epilepsy, metallic implants in head and neck areas

Patients under steroid medication for a duration of more than six months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath